Cargando…
Molecular Engines, Therapeutic Targets, and Challenges in Pediatric Brain Tumors: A Special Emphasis on Hydrogen Sulfide and RNA-Based Nano-Delivery
SIMPLE SUMMARY: Pediatric brain tumors represent a formidable challenge in the field of oncology. Pediatric brain tumors are sub-classified into several molecular sub-types, where each one is characterized by an array of hyperactivated oncogenic molecular engines. However, there have been great effo...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657918/ https://www.ncbi.nlm.nih.gov/pubmed/36358663 http://dx.doi.org/10.3390/cancers14215244 |
_version_ | 1784829816614158336 |
---|---|
author | Fahmy, Sherif Ashraf Dawoud, Alyaa Zeinelabdeen, Yousra Ahmed Kiriacos, Caroline Joseph Daniel, Kerolos Ashraf Eltahtawy, Omar Abdelhalim, Miriam Mokhtar Braoudaki, Maria Youness, Rana A. |
author_facet | Fahmy, Sherif Ashraf Dawoud, Alyaa Zeinelabdeen, Yousra Ahmed Kiriacos, Caroline Joseph Daniel, Kerolos Ashraf Eltahtawy, Omar Abdelhalim, Miriam Mokhtar Braoudaki, Maria Youness, Rana A. |
author_sort | Fahmy, Sherif Ashraf |
collection | PubMed |
description | SIMPLE SUMMARY: Pediatric brain tumors represent a formidable challenge in the field of oncology. Pediatric brain tumors are sub-classified into several molecular sub-types, where each one is characterized by an array of hyperactivated oncogenic molecular engines. However, there have been great efforts dedicated to portray the involved signaling pathways driving pediatric brain tumors. Yet, a full understanding of the intertwined oncogenic pathways involved is still obscure. In this review, the authors shed light on novel therapeutic targets tailored for several sub-types of pediatric brain tumors and point out the limitations of such therapeutic approaches. Hydrogen Sulfide (H(2)S) has recently been cast as an oncogenic driver in several solid malignancies, yet its role in brain tumors is still under investigation. The authors also highlight the possible involvement of H(2)S in pediatric brain tumors and propose promising brain-delivery strategies for the sake of achieving better therapeutic results for brain tumors patients. ABSTRACT: Pediatric primary brain tumors represent a real challenge in the oncology arena. Besides the psychosocial burden, brain tumors are considered one of the most difficult-to-treat malignancies due to their sophisticated cellular and molecular pathophysiology. Notwithstanding the advances in research and the substantial efforts to develop a suitable therapy, a full understanding of the molecular pathways involved in primary brain tumors is still demanded. On the other hand, the physiological nature of the blood–brain barrier (BBB) limits the efficiency of many available treatments, including molecular therapeutic approaches. Hydrogen Sulfide (H(2)S), as a member of the gasotransmitters family, and its synthesizing machinery have represented promising molecular targets for plentiful cancer types. However, its role in primary brain tumors, generally, and pediatric types, particularly, is barely investigated. In this review, the authors shed the light on the novel role of hydrogen sulfide (H(2)S) as a prominent player in pediatric brain tumor pathophysiology and its potential as a therapeutic avenue for brain tumors. In addition, the review also focuses on the challenges and opportunities of several molecular targeting approaches and proposes promising brain-delivery strategies for the sake of achieving better therapeutic results for brain tumor patients. |
format | Online Article Text |
id | pubmed-9657918 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96579182022-11-15 Molecular Engines, Therapeutic Targets, and Challenges in Pediatric Brain Tumors: A Special Emphasis on Hydrogen Sulfide and RNA-Based Nano-Delivery Fahmy, Sherif Ashraf Dawoud, Alyaa Zeinelabdeen, Yousra Ahmed Kiriacos, Caroline Joseph Daniel, Kerolos Ashraf Eltahtawy, Omar Abdelhalim, Miriam Mokhtar Braoudaki, Maria Youness, Rana A. Cancers (Basel) Review SIMPLE SUMMARY: Pediatric brain tumors represent a formidable challenge in the field of oncology. Pediatric brain tumors are sub-classified into several molecular sub-types, where each one is characterized by an array of hyperactivated oncogenic molecular engines. However, there have been great efforts dedicated to portray the involved signaling pathways driving pediatric brain tumors. Yet, a full understanding of the intertwined oncogenic pathways involved is still obscure. In this review, the authors shed light on novel therapeutic targets tailored for several sub-types of pediatric brain tumors and point out the limitations of such therapeutic approaches. Hydrogen Sulfide (H(2)S) has recently been cast as an oncogenic driver in several solid malignancies, yet its role in brain tumors is still under investigation. The authors also highlight the possible involvement of H(2)S in pediatric brain tumors and propose promising brain-delivery strategies for the sake of achieving better therapeutic results for brain tumors patients. ABSTRACT: Pediatric primary brain tumors represent a real challenge in the oncology arena. Besides the psychosocial burden, brain tumors are considered one of the most difficult-to-treat malignancies due to their sophisticated cellular and molecular pathophysiology. Notwithstanding the advances in research and the substantial efforts to develop a suitable therapy, a full understanding of the molecular pathways involved in primary brain tumors is still demanded. On the other hand, the physiological nature of the blood–brain barrier (BBB) limits the efficiency of many available treatments, including molecular therapeutic approaches. Hydrogen Sulfide (H(2)S), as a member of the gasotransmitters family, and its synthesizing machinery have represented promising molecular targets for plentiful cancer types. However, its role in primary brain tumors, generally, and pediatric types, particularly, is barely investigated. In this review, the authors shed the light on the novel role of hydrogen sulfide (H(2)S) as a prominent player in pediatric brain tumor pathophysiology and its potential as a therapeutic avenue for brain tumors. In addition, the review also focuses on the challenges and opportunities of several molecular targeting approaches and proposes promising brain-delivery strategies for the sake of achieving better therapeutic results for brain tumor patients. MDPI 2022-10-26 /pmc/articles/PMC9657918/ /pubmed/36358663 http://dx.doi.org/10.3390/cancers14215244 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Fahmy, Sherif Ashraf Dawoud, Alyaa Zeinelabdeen, Yousra Ahmed Kiriacos, Caroline Joseph Daniel, Kerolos Ashraf Eltahtawy, Omar Abdelhalim, Miriam Mokhtar Braoudaki, Maria Youness, Rana A. Molecular Engines, Therapeutic Targets, and Challenges in Pediatric Brain Tumors: A Special Emphasis on Hydrogen Sulfide and RNA-Based Nano-Delivery |
title | Molecular Engines, Therapeutic Targets, and Challenges in Pediatric Brain Tumors: A Special Emphasis on Hydrogen Sulfide and RNA-Based Nano-Delivery |
title_full | Molecular Engines, Therapeutic Targets, and Challenges in Pediatric Brain Tumors: A Special Emphasis on Hydrogen Sulfide and RNA-Based Nano-Delivery |
title_fullStr | Molecular Engines, Therapeutic Targets, and Challenges in Pediatric Brain Tumors: A Special Emphasis on Hydrogen Sulfide and RNA-Based Nano-Delivery |
title_full_unstemmed | Molecular Engines, Therapeutic Targets, and Challenges in Pediatric Brain Tumors: A Special Emphasis on Hydrogen Sulfide and RNA-Based Nano-Delivery |
title_short | Molecular Engines, Therapeutic Targets, and Challenges in Pediatric Brain Tumors: A Special Emphasis on Hydrogen Sulfide and RNA-Based Nano-Delivery |
title_sort | molecular engines, therapeutic targets, and challenges in pediatric brain tumors: a special emphasis on hydrogen sulfide and rna-based nano-delivery |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657918/ https://www.ncbi.nlm.nih.gov/pubmed/36358663 http://dx.doi.org/10.3390/cancers14215244 |
work_keys_str_mv | AT fahmysherifashraf molecularenginestherapeutictargetsandchallengesinpediatricbraintumorsaspecialemphasisonhydrogensulfideandrnabasednanodelivery AT dawoudalyaa molecularenginestherapeutictargetsandchallengesinpediatricbraintumorsaspecialemphasisonhydrogensulfideandrnabasednanodelivery AT zeinelabdeenyousraahmed molecularenginestherapeutictargetsandchallengesinpediatricbraintumorsaspecialemphasisonhydrogensulfideandrnabasednanodelivery AT kiriacoscarolinejoseph molecularenginestherapeutictargetsandchallengesinpediatricbraintumorsaspecialemphasisonhydrogensulfideandrnabasednanodelivery AT danielkerolosashraf molecularenginestherapeutictargetsandchallengesinpediatricbraintumorsaspecialemphasisonhydrogensulfideandrnabasednanodelivery AT eltahtawyomar molecularenginestherapeutictargetsandchallengesinpediatricbraintumorsaspecialemphasisonhydrogensulfideandrnabasednanodelivery AT abdelhalimmiriammokhtar molecularenginestherapeutictargetsandchallengesinpediatricbraintumorsaspecialemphasisonhydrogensulfideandrnabasednanodelivery AT braoudakimaria molecularenginestherapeutictargetsandchallengesinpediatricbraintumorsaspecialemphasisonhydrogensulfideandrnabasednanodelivery AT younessranaa molecularenginestherapeutictargetsandchallengesinpediatricbraintumorsaspecialemphasisonhydrogensulfideandrnabasednanodelivery |